A Phase 2 ophthalmic trial of EOM147 for macular edema in patients with wet age-related macular degeneration (wet-AMD)
Latest Information Update: 10 Dec 2021
At a glance
- Drugs Squalamine (Primary)
- Indications Diabetic macular oedema; Wet age-related macular degeneration
- Focus Therapeutic Use
- 10 Dec 2021 New trial record